{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:23:37Z","timestamp":1790400217621,"version":"4.1.0"},"publisher-location":"Cham","reference-count":97,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319779317","type":"print"},{"value":"9783319779324","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-77932-4_36","type":"book-chapter","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T10:13:47Z","timestamp":1532600027000},"page":"589-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Precision Medicine and Personalized Medicine in Cardiovascular Disease"],"prefix":"10.1007","author":[{"given":"Gemma","family":"Currie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"issue":"3","key":"36_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"7","key":"36_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"36_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl 1):S11\u201324.","journal-title":"Diabetes Care"},{"issue":"27","key":"36_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"key":"36_CR5","unstructured":"Medical Research Council. Stratified medicine. https:\/\/www.mrc.ac.uk\/research\/initiatives\/stratified-medicine\/ . Accessed 7 Jan 2018."},{"key":"36_CR6","unstructured":"National Health Service. Improving outcomes through personalised medicine. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2016\/09\/improving-outcomes-personalised-medicine.pdf . Accessed 7 Jan 2018."},{"key":"36_CR7","volume-title":"Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease","author":"National Research Council (US) Committee on A framework for developing a new taxonomy of disease","year":"2011","unstructured":"National Research Council (US) Committee on A framework for developing a new taxonomy of disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academic Press (US); 2011."},{"key":"36_CR8","unstructured":"President Obama\u2019s Precision Medicine Initiative. https:\/\/obamawhitehouse.archives.gov\/the-press-office\/2015\/01\/30\/fact-sheet-president-obama-s-precision-medicine-initiative . Accessed 7 Jan 2018."},{"key":"36_CR9","unstructured":"Smith R. Stratified, personalised, or precision medicine. http:\/\/blogs.bmj.com\/bmj\/2012\/10\/15\/richard-smith-stratified-personalised-or-precision-medicine\/ . Accessed 7 Jan 2018."},{"issue":"4","key":"36_CR10","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1161\/HYPERTENSIONAHA.116.08252","volume":"69","author":"A Dominiczak","year":"2017","unstructured":"Dominiczak A, Delles C, Padmanabhan S. Genomics and precision medicine for clinicians and scientists in hypertension. Hypertension. 2017;69(4):e10\u20133.","journal-title":"Hypertension"},{"issue":"4","key":"36_CR11","doi-asserted-by":"publisher","first-page":"1700391","DOI":"10.1183\/13993003.00391-2017","volume":"50","author":"IR Konig","year":"2017","unstructured":"Konig IR, Fuchs O, Hansen G, von Mutius E, Kopp MV. What is precision medicine? Eur Respir J. 2017;50(4):1700391.","journal-title":"Eur Respir J"},{"issue":"9963","key":"36_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117\u201371.","journal-title":"Lancet"},{"issue":"9982","key":"36_CR13","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0140-6736(15)60722-X","volume":"385","author":"VJ Dzau","year":"2015","unstructured":"Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to fulfil the promise of personalised medicine. Lancet. 2015;385(9982):2118\u20139.","journal-title":"Lancet"},{"issue":"10085","key":"36_CR14","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351.","journal-title":"Lancet"},{"issue":"2","key":"36_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/genes6020372","volume":"6","author":"R Dorajoo","year":"2015","unstructured":"Dorajoo R, Liu J, Boehm BO. Genetics of type 2 diabetes and clinical utility. Genes (Basel). 2015;6(2):372\u201384.","journal-title":"Genes (Basel)"},{"issue":"5","key":"36_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s11906-010-0134-2","volume":"12","author":"GP Rossi","year":"2010","unstructured":"Rossi GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep. 2010;12(5):342\u20138.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"36_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MED.0000000000000255","volume":"23","author":"EA Azizan","year":"2016","unstructured":"Azizan EA, Brown MJ. Novel genetic determinants of adrenal aldosterone regulation. Curr Opin Endocrinol Diabetes Obes. 2016;23(3):209\u201317.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"36_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.118","volume":"40","author":"W Ji","year":"2008","unstructured":"Ji W, Foo JN, O\u2019Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40(5):592\u20139.","journal-title":"Nat Genet"},{"issue":"2","key":"36_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.mnh.0000441151.55320.c3","volume":"23","author":"J Titze","year":"2014","unstructured":"Titze J. Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens. 2014;23(2):101\u20135.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"36_CR20","unstructured":"National Institute for Health and Clinical Excellence. Hypertension in adults: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/cg127 . Accessed 7 Jan 2018."},{"issue":"5","key":"36_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0002-9149(75)90168-X","volume":"36","author":"FR Buhler","year":"1975","unstructured":"Buhler FR, Burkart F, Lutold BE, Kung M, Marbet G, Pfisterer M. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol. 1975;36(5):653\u201369.","journal-title":"Am J Cardiol"},{"issue":"10008","key":"36_CR22","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386(10008):2059\u201368.","journal-title":"Lancet"},{"issue":"3","key":"36_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12265-017-9756-y","volume":"10","author":"SJ Shah","year":"2017","unstructured":"Shah SJ. Precision medicine for heart failure with preserved ejection fraction: an overview. J Cardiovasc Transl Res. 2017;10(3):233\u201344.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"36_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12265-017-9759-8","volume":"10","author":"SJ Shah","year":"2017","unstructured":"Shah SJ. Innovative clinical trial designs for precision medicine in heart failure with preserved ejection fraction. J Cardiovasc Transl Res. 2017;10(3):322\u201336.","journal-title":"J Cardiovasc Transl Res"},{"issue":"10060","key":"36_CR25","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","volume":"388","author":"MH Olsen","year":"2016","unstructured":"Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the lancet commission on hypertension. Lancet. 2016;388(10060):2665\u2013712.","journal-title":"Lancet"},{"issue":"1","key":"36_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/HCG.0000000000000020","volume":"8","author":"K Musunuru","year":"2015","unstructured":"Musunuru K, Hickey KT, Al-Khatib SM, Delles C, Fornage M, Fox CS, et al. Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. Circ Cardiovasc Genet. 2015;8(1):216\u201342.","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"36_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcin.2017.07.022","volume":"11","author":"LH Cavallari","year":"2017","unstructured":"Cavallari LH, Lee CR, Beitelshees AL, RM C-DH, Duarte JD, Voora D, et al. Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention. JACC Cardiovasc Interv. 2017;11(2):181\u201391.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7404","key":"36_CR28","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","volume":"326","author":"NJ Wald","year":"2003","unstructured":"Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.","journal-title":"BMJ"},{"issue":"1","key":"36_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cell.2014.02.012","volume":"157","author":"EJ Topol","year":"2014","unstructured":"Topol EJ. Individualized medicine from prewomb to tomb. Cell. 2014;157(1):241\u201353.","journal-title":"Cell"},{"issue":"8","key":"36_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/biot.201100297","volume":"7","author":"R Snyderman","year":"2012","unstructured":"Snyderman R. Personalized health care: from theory to practice. Biotechnol J. 2012;7(8):973\u20139.","journal-title":"Biotechnol J"},{"key":"36_CR31","unstructured":"US Department of Veterans Affairs. VA Million Veteran Program linked to precision medicine effort. https:\/\/www.research.va.gov\/pubs\/varqu\/spring2016\/13.cfm . Accessed 7 Jan 2018."},{"key":"36_CR32","unstructured":"UK Biobank. http:\/\/www.ukbiobank.ac.uk \/. Accessed 7 Jan 2018."},{"issue":"4 Pt 1","key":"36_CR33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/0002-8703(91)90694-D","volume":"121","author":"V Dzau","year":"1991","unstructured":"Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991;121(4 Pt 1):1244\u201363.","journal-title":"Am Heart J"},{"issue":"4","key":"36_CR34","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1152\/physrev.00035.2016","volume":"97","author":"S Padmanabhan","year":"2017","unstructured":"Padmanabhan S, Joe B. Towards precision medicine for hypertension: a review of genomic, Epigenomic, and Microbiomic effects on blood pressure in experimental rat models and humans. Physiol Rev. 2017;97(4):1469\u2013528.","journal-title":"Physiol Rev"},{"issue":"10","key":"36_CR35","doi-asserted-by":"publisher","first-page":"e0187240","DOI":"10.1371\/journal.pone.0187240","volume":"12","author":"D Sun","year":"2017","unstructured":"Sun D, Liu J, Xiao L, Liu Y, Wang Z, Li C, et al. Recent development of risk-prediction models for incident hypertension: an updated systematic review. PLoS One. 2017;12(10):e0187240.","journal-title":"PLoS One"},{"issue":"22","key":"36_CR36","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1042\/CS20160407","volume":"131","author":"C Savoia","year":"2017","unstructured":"Savoia C, Volpe M, Grassi G, Borghi C, Agabiti Rosei E, Touyz RM. Personalized medicine-a modern approach for the diagnosis and management of hypertension. Clin Sci (Lond). 2017;131(22):2671\u201385.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"36_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.amjmed.2016.11.021","volume":"130","author":"JA Ladapo","year":"2017","unstructured":"Ladapo JA, Budoff M, Sharp D, Zapien M, Huang L, Maniet B, et al. Clinical utility of a precision medicine test evaluating outpatients with suspected obstructive coronary artery disease. Am J Med. 2017;130(4):482. e411\u2013482.e417","journal-title":"Am J Med"},{"key":"36_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","volume":"248","author":"G Niccoli","year":"2017","unstructured":"Niccoli G, Montone RA, Lanza GA, Crea F. Angina after percutaneous coronary intervention: the need for precision medicine. Int J Cardiol. 2017;248:14\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"36_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.116.027134","volume":"136","author":"BP Halliday","year":"2017","unstructured":"Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future. Circulation. 2017;136(2):215\u201331.","journal-title":"Circulation"},{"issue":"6","key":"36_CR40","doi-asserted-by":"publisher","first-page":"e001826","DOI":"10.1161\/CIRCGENETICS.117.001826","volume":"10","author":"DD Kinnamon","year":"2017","unstructured":"Kinnamon DD, Morales A, Bowen DJ, Burke W, Hershberger RE, DCM Consortium*. Toward genetics-driven early intervention in dilated cardiomyopathy: design and implementation of the DCM precision medicine study. Circ Cardiovasc Genet. 2017;10(6):e001826.","journal-title":"Circ Cardiovasc Genet"},{"issue":"10","key":"36_CR41","doi-asserted-by":"publisher","first-page":"e004111","DOI":"10.1161\/CIRCHEARTFAILURE.117.004111","volume":"10","author":"ME Nassif","year":"2017","unstructured":"Nassif ME, Tang Y, Cleland JG, Abraham WT, Linde C, Gold MR, et al. Precision medicine for cardiac resynchronization: predicting quality of life benefits for individual patients-an analysis from 5 clinical trials. Circ Heart Fail. 2017;10(10):e004111.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"36_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCGENETICS.111.961342","volume":"5","author":"G Thanassoulis","year":"2012","unstructured":"Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham heart study. Circ Cardiovasc Genet. 2012;5(1):113\u201321.","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"36_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/17425255.2017.1363887","volume":"13","author":"E Berinstein","year":"2017","unstructured":"Berinstein E, Levy A. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments. Expert Opin Drug Metab Toxicol. 2017;13(9):973\u201383.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"36_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40142-016-0096-z","volume":"4","author":"S Tuteja","year":"2016","unstructured":"Tuteja S, Limdi N. Pharmacogenetics in cardiovascular medicine. Curr Genet Med Rep. 2016;4(3):119\u201329.","journal-title":"Curr Genet Med Rep"},{"issue":"1","key":"36_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845.","journal-title":"Nat Commun"},{"issue":"6","key":"36_CR46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ajhg.2017.09.028","volume":"101","author":"MA Richard","year":"2017","unstructured":"Richard MA, Huan T, Ligthart S, Gondalia R, Jhun MA, Brody JA, et al. DNA methylation analysis identifies loci for blood pressure regulation. Am J Hum Genet. 2017;101(6):888\u2013902.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"36_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-017-01297-7","volume":"8","author":"AY Chu","year":"2017","unstructured":"Chu AY, Tin A, Schlosser P, Ko YA, Qiu C, Yao C, et al. Epigenome-wide association studies identify DNA methylation associated with kidney function. Nat Commun. 2017;8(1):1286.","journal-title":"Nat Commun"},{"issue":"11","key":"36_CR48","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCRESAHA.116.310324","volume":"120","author":"J Li","year":"2017","unstructured":"Li J, Zhu X, Yu K, Jiang H, Zhang Y, Deng S, et al. Genome-wide analysis of DNA methylation and acute coronary syndrome. Circ Res. 2017;120(11):1754\u201367.","journal-title":"Circ Res"},{"issue":"1","key":"36_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13059-016-1119-5","volume":"17","author":"S Ligthart","year":"2016","unstructured":"Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.","journal-title":"Genome Biol"},{"issue":"1","key":"36_CR50","doi-asserted-by":"publisher","first-page":"e1002215","DOI":"10.1371\/journal.pmed.1002215","volume":"14","author":"MM Mendelson","year":"2017","unstructured":"Mendelson MM, Marioni RE, Joehanes R, Liu C, Hedman AK, Aslibekyan S, et al. Association of Body Mass Index with DNA methylation and gene expression in blood cells and relations to Cardiometabolic disease: a Mendelian randomization approach. PLoS Med. 2017;14(1):e1002215.","journal-title":"PLoS Med"},{"issue":"9","key":"36_CR51","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/CIR.0000000000000226","volume":"132","author":"ML Lindsey","year":"2015","unstructured":"Lindsey ML, Mayr M, Gomes AV, Delles C, Arrell DK, Murphy AM, et al. Transformative impact of proteomics on cardiovascular health and disease: a scientific statement from the American Heart Association. Circulation. 2015;132(9):852\u201372.","journal-title":"Circulation"},{"issue":"11","key":"36_CR52","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1097\/HJH.0b013e32833d81b7","volume":"28","author":"C Delles","year":"2010","unstructured":"Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, et al. Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens. 2010;28(11):2316\u201322.","journal-title":"J Hypertens"},{"issue":"11","key":"36_CR53","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","volume":"9","author":"DM Good","year":"2010","unstructured":"Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010;9(11):2424\u201337.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"36_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.110.164285","volume":"57","author":"DM Carty","year":"2011","unstructured":"Carty DM, Siwy J, Brennand JE, Zurbig P, Mullen W, Franke J, et al. Urinary proteomics for prediction of preeclampsia. Hypertension. 2011;57(3):561\u20139.","journal-title":"Hypertension"},{"issue":"6","key":"36_CR55","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/HYPERTENSIONAHA.113.01168","volume":"61","author":"JE Myers","year":"2013","unstructured":"Myers JE, Tuytten R, Thomas G, Laroy W, Kas K, Vanpoucke G, et al. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension. 2013;61(6):1281\u20138.","journal-title":"Hypertension"},{"issue":"5\u20136","key":"36_CR56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/prca.201400195","volume":"9","author":"CE Brown","year":"2015","unstructured":"Brown CE, McCarthy NS, Hughes AD, Sever P, Stalmach A, Mullen W, et al. Urinary proteomic biomarkers to predict cardiovascular events. Proteomics Clin Appl. 2015;9(5\u20136):610\u20137.","journal-title":"Proteomics Clin Appl"},{"issue":"10","key":"36_CR57","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.117.028213","volume":"37","author":"SA Williams","year":"2017","unstructured":"Williams SA, Murthy AC, DeLisle RK, Hyde C, Malarstig A, Ostroff R, et al. Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of Torcetrapib. Circulation. 2017;37(10):999\u20131010.","journal-title":"Circulation"},{"issue":"6","key":"36_CR58","doi-asserted-by":"publisher","first-page":"e001808","DOI":"10.1161\/CIRCGENETICS.117.001808","volume":"10","author":"X Yin","year":"2017","unstructured":"Yin X, Baig F, Haudebourg E, Blankley RT, Gandhi T, Muller S, et al. Plasma proteomics for epidemiology: increasing throughput with standard-flow rates. Circ Cardiovasc Genet. 2017;10(6):e001808.","journal-title":"Circ Cardiovasc Genet"},{"key":"36_CR59","doi-asserted-by":"crossref","unstructured":"Barba I, Andres M, Dorado DG. Metabolomics and heart diseases: from basic to clinical approach. Curr Med Chem. 2017. https:\/\/doi.org\/10.2174\/0929867324666171006151408 .","DOI":"10.2174\/0929867324666171006151408"},{"issue":"3","key":"36_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.1073","volume":"44","author":"J Kettunen","year":"2012","unstructured":"Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikainen LP, et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet. 2012;44(3):269\u201376.","journal-title":"Nat Genet"},{"key":"36_CR61","doi-asserted-by":"crossref","unstructured":"Delles C, Rankin NJ, Boachie C, McConnachie A, Ford I, Kangas A, et al. Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. Eur J Heart Fail. 2017. https:\/\/doi.org\/10.1002\/ejhf.1076 .","DOI":"10.1002\/ejhf.1076"},{"issue":"2","key":"36_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.115.05544","volume":"66","author":"C Menni","year":"2015","unstructured":"Menni C, Graham D, Kastenmuller G, Alharbi NH, Alsanosi SM, McBride M, et al. Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension. 2015;66(2):422\u20139.","journal-title":"Hypertension"},{"issue":"10","key":"36_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, et al. Metabolomics enables precision medicine: \u201cA white paper, community perspective\u201d. Metabolomics. 2016;12(10):149.","journal-title":"Metabolomics"},{"issue":"12","key":"36_CR64","doi-asserted-by":"publisher","first-page":"e007402","DOI":"10.1161\/JAHA.117.007402","volume":"6","author":"PR Lawler","year":"2017","unstructured":"Lawler PR, Akinkuolie AO, Harada P, Glynn RJ, Chasman DI, Ridker PM, et al. Residual risk of atherosclerotic cardiovascular events in relation to reductions in very-low-density lipoproteins. J Am Heart Assoc. 2017;6(12):e007402.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"36_CR65","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/annrheumdis-2013-204345","volume":"74","author":"IB McInnes","year":"2015","unstructured":"McInnes IB, Thompson L, Giles JT, Bathon JM, Salmon JE, Beaulieu AD, et al. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2015;74(4):694\u2013702.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"36_CR66","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cpet.2017.05.008","volume":"12","author":"EH Dibble","year":"2017","unstructured":"Dibble EH, Yoo DC. Precision medicine and PET\/computed tomography in cardiovascular disorders. PET Clin. 2017;12(4):459\u201373.","journal-title":"PET Clin"},{"issue":"11","key":"36_CR67","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jacc.2017.07.750","volume":"70","author":"HL Teague","year":"2017","unstructured":"Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, et al. Unraveling vascular inflammation: from immunology to imaging. J Am Coll Cardiol. 2017;70(11):1403\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"36_CR68","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2017.14172","volume":"318","author":"E Futier","year":"2017","unstructured":"Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346\u201357.","journal-title":"JAMA"},{"issue":"46","key":"36_CR69","doi-asserted-by":"publisher","first-page":"e8748","DOI":"10.1097\/MD.0000000000008748","volume":"96","author":"PK Bundhun","year":"2017","unstructured":"Bundhun PK, Gupta C, Huang F. Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: a meta-analysis. Medicine (Baltimore). 2017;96(46):e8748.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"36_CR70","doi-asserted-by":"publisher","first-page":"e0187809","DOI":"10.1371\/journal.pone.0187809","volume":"12","author":"JE Lucas","year":"2017","unstructured":"Lucas JE, Bazemore TC, Alo C, Monahan PB, Voora D. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States military health system. PLoS One. 2017;12(11):e0187809.","journal-title":"PLoS One"},{"key":"36_CR71","doi-asserted-by":"crossref","unstructured":"Wu PY, Cheng CW, Kaddi C, Venugopalan J, Hoffman R, Wang MD. Advanced big data analytics for -Omic data and electronic health records: toward precision medicine. IEEE Trans Biomed Eng. 2017;64(2):263\u20133.","DOI":"10.1109\/TBME.2016.2573285"},{"issue":"11","key":"36_CR72","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/ng.3968","volume":"49","author":"JA Brody","year":"2017","unstructured":"Brody JA, Morrison AC, Bis JC, O\u2019Connell JR, Brown MR, Huffman JE, et al. Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology. Nat Genet. 2017;49(11):1560\u20133.","journal-title":"Nat Genet"},{"issue":"23","key":"36_CR73","first-page":"1805","volume":"38","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J. 2017;38(23):1805\u201314.","journal-title":"Eur Heart J"},{"issue":"21","key":"36_CR74","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1016\/j.jacc.2017.03.571","volume":"69","author":"C Krittanawong","year":"2017","unstructured":"Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. Artificial intelligence in precision cardiovascular medicine. J Am Coll Cardiol. 2017;69(21):2657\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"36_CR75","doi-asserted-by":"publisher","first-page":"20170021","DOI":"10.1098\/rsfs.2017.0021","volume":"8","author":"C Capelli","year":"2018","unstructured":"Capelli C, Sauvage E, Giusti G, Bosi GM, Ntsinjana H, Carminati M, et al. Patient-specific simulations for planning treatment in congenital heart disease. Interface Focus. 2018;8(1):20170021.","journal-title":"Interface Focus"},{"issue":"7","key":"36_CR76","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/heartjnl-2017-311449","volume":"104","author":"K Mangion","year":"2017","unstructured":"Mangion K, Gao H, Husmeier D, Luo X, Berry C. Advances in computational modelling for personalised medicine after myocardial infarction. Heart. 2017;104(7):550\u20137.","journal-title":"Heart"},{"issue":"1","key":"36_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.recesp.2017.06.032","volume":"71","author":"S Ye","year":"2018","unstructured":"Ye S, Kronish IM. To persist or not to persist: learning from precision medicine to optimize statin adherence. Rev Esp Cardiol (Engl Ed). 2018;71(1):4\u20135.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"36_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/1467-9566.12457","volume":"39","author":"S Day","year":"2017","unstructured":"Day S, Coombes RC, McGrath-Lone L, Schoenborn C, Ward H. Stratified, precision or personalised medicine? Cancer services in the \u2018real world\u2019 of a London hospital. Sociol Health Illn. 2017;39(1):143\u201358.","journal-title":"Sociol Health Illn"},{"issue":"5","key":"36_CR79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2217\/pme-2017-0022","volume":"14","author":"C Mukherjee","year":"2017","unstructured":"Mukherjee C, Sweet KM, Luzum JA, Abdel-Rasoul M, Christman MF, Kitzmiller JP. Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort. Per Med. 2017;14(5):383\u20138.","journal-title":"Per Med"},{"issue":"21","key":"36_CR80","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207.","journal-title":"N Engl J Med"},{"issue":"22","key":"36_CR81","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","journal-title":"N Engl J Med"},{"issue":"3","key":"36_CR82","doi-asserted-by":"publisher","first-page":"e010310","DOI":"10.1136\/bmjopen-2015-010310","volume":"6","author":"M Lindhardt","year":"2016","unstructured":"Lindhardt M, Persson F, Currie G, Pontillo C, Beige J, Delles C, et al. Proteomic prediction and renin angiotensin aldosterone system inhibition prevention of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open. 2016;6(3):e010310.","journal-title":"BMJ Open"},{"key":"36_CR83","unstructured":"Academy of Medical Sciences. Realising the potential of stratified medicine. https:\/\/acmedsci.ac.uk\/viewFile\/51e915f9f09fb.pdf . Accessed 7 Jan 2018."},{"issue":"2","key":"36_CR84","doi-asserted-by":"publisher","first-page":"1700074","DOI":"10.1002\/prca.201700074","volume":"12","author":"Agnieszka Latosinska","year":"2017","unstructured":"Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Clinical proteomics for precision medicine: the bladder cancer case. Proteomics Clin Appl. 2017;12(2). https:\/\/doi.org\/10.1002\/prca.201700074 .","journal-title":"PROTEOMICS - Clinical Applications"},{"issue":"6","key":"36_CR85","doi-asserted-by":"publisher","first-page":"e004202","DOI":"10.1161\/CIRCHEARTFAILURE.117.004202","volume":"10","author":"AM Feldman","year":"2017","unstructured":"Feldman AM, Kontos CD, McClung JM, Gerhard GS, Khalili K, Cheung JY. Precision medicine for heart failure: lessons from oncology. Circ Heart Fail. 2017;10(6):e004202.","journal-title":"Circ Heart Fail"},{"issue":"20","key":"36_CR86","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular complications of Cancer therapy: best practices in diagnosis, prevention, and management: part 1. J Am Coll Cardiol. 2017;70(20):2536\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"36_CR87","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH. Cardiovascular complications of Cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol. 2017;70(20):2552\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"36_CR88","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/CIRCOUTCOMES.110.868307","volume":"3","author":"C Melloni","year":"2010","unstructured":"Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3(2):135\u201342.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"36_CR89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1042\/BIO03901004","volume":"39","author":"JF Reckelhoff","year":"2017","unstructured":"Reckelhoff JF, Cordozo LLY. As precision medicine becomes more important, is it finally time for increased emphasis on gender medicine? Biochemist. 2017;39:4\u20135.","journal-title":"Biochemist"},{"issue":"12","key":"36_CR90","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1089\/jwh.2015.5498","volume":"24","author":"VM Miller","year":"2015","unstructured":"Miller VM, Rocca WA, Faubion SS. Sex differences research, precision medicine, and the future of Women\u2019s health. J Womens Health (Larchmt). 2015;24(12):969\u201371.","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"36_CR91","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1177\/1557988315595693","volume":"11","author":"DA Mata","year":"2017","unstructured":"Mata DA, Katchi FM, Ramasamy R. Precision medicine and men\u2019s health. Am J Mens Health. 2017;11(4):1124\u20139.","journal-title":"Am J Mens Health"},{"issue":"6","key":"36_CR92","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Riet Te","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116(6):960\u201375.","journal-title":"Circ Res"},{"issue":"12","key":"36_CR93","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/omi.2017.0149","volume":"21","author":"E Giannakopoulou","year":"2017","unstructured":"Giannakopoulou E, Konstantinou F, Ragia G, Tavridou A, Karaglani M, Chatzaki E, et al. Epigenetics-by-sex interaction for coronary artery disease risk conferred by the cystathionine gamma-Lyase gene promoter methylation. OMICS. 2017;21(12):741\u20138.","journal-title":"OMICS"},{"key":"36_CR94","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jprot.2017.11.012","volume":"173","author":"R Baetta","year":"2017","unstructured":"Baetta R, Pontremoli M, Martinez Fernandez A, Spickett CM, Banfi C. Proteomics in cardiovascular diseases: unveiling sex and gender differences in the era of precision medicine. J Proteome. 2017;173:62\u201376.","journal-title":"J Proteome"},{"issue":"3","key":"36_CR95","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/bph.12362","volume":"171","author":"F Franconi","year":"2014","unstructured":"Franconi F, Campesi I. Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol. 2014;171(3):580\u201394.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"36_CR96","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/CS20160379","volume":"131","author":"L Gaignebet","year":"2017","unstructured":"Gaignebet L, Kararigas G. En route to precision medicine through the integration of biological sex into pharmacogenomics. Clin Sci (Lond). 2017;131(4):329\u201342.","journal-title":"Clin Sci (Lond)"},{"key":"36_CR97","unstructured":"Academy of Medical Sciences. Stratified, personalised or P4 medicine: a new direction for placing the patient at the centre of healthcare and health education. May 2015. https:\/\/acmedsci.ac.uk\/viewFile\/564091e072d41.pdf . Accessed 7 Jan 2018."}],"container-title":["Advances in Experimental Medicine and Biology","Sex-Specific Analysis of Cardiovascular Function"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-77932-4_36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T15:01:18Z","timestamp":1604674878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-77932-4_36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319779317","9783319779324"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-77932-4_36","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}